Therapeutic Updates for Follicular and Marginal Zone Lymphoma

Loretta J. Nastoupil, MD, reviews prognostic biomarkers to advance the timely identification and risk assessment of patients with follicular lymphoma (FL) for prompt treatment and/or referrals. Dr. Nastoupil also describes current treatment options for patients with multiple relapses in the management of FL, and discusses the efficacy and safety data for agents in late stage of development and in patients who have experienced multiple relapses.

Back to Symposium Page »


March 20, 2021

Created by

Scripps CME Connection

Related Presenters

Loretta Nastoupil, MD

Loretta Nastoupil, MD

Associate Professor
Department of Lymphoma/Myeloma, Division of Cancer Medicine
Section Chief, Indolent Lymphoma; Section Chief, New Drug Development
The University of Texas MD Anderson Cancer Center

Dr. Loretta J. Nastoupil is an Associate Professor in the Department of Lymphoma/Myeloma at the University of Texas MD Anderson Cancer Center in Houston, TX USA. She is Section Chief of the indolent lymphoma and new drug development teams ...

View full profile